High Tide Reports Strong Q1 Earnings, Revenue Surges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy HITI?
Source: seekingalpha
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million for the three months ended January 31, 2026, reflecting a 25.2% year-over-year increase and exceeding market expectations by $51.47 million, demonstrating the company's ability to sustain growth in a competitive market.
- Record Gross Profit: The gross profit for the quarter reached $44.4 million, up 25% year-over-year and 4% sequentially, with a gross margin of 25%, indicating ongoing improvements in cost control and sales efficiency.
- Substantial Free Cash Flow Improvement: The company generated $2.9 million in free cash flow in Q1, a significant turnaround from $(1.9) million year-over-year and $1.3 million sequentially, enhancing its financial stability and operational flexibility.
- Net Loss Reduction: Although the company reported a net loss of $0.4 million in Q1, this marked a significant improvement from a net loss of $2.7 million year-over-year and $46.7 million sequentially, primarily due to reduced non-cash impairment expenses, indicating progress in profitability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HITI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HITI
Wall Street analysts forecast HITI stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.320
Low
7.50
Averages
7.50
High
7.50
Current: 2.320
Low
7.50
Averages
7.50
High
7.50
About HITI
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include bricks-and-mortar, e-commerce and medical cannabis distribution. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries and supports the distribution of accessories and other items to the United States. The medical cannabis distribution segment includes the medical cannabis distribution operations. It offers a suite of proprietary brands which include Dopezilla, Atomik, Puff Puff Pass, Vodka Glass, Queen of Bud, and Cabana Cannabis Co. Canna Cabana is the Company’s primary retail cannabis business, offering the retail sale of various cannabis products and accessories through its provincially authorized cannabis retail store locations. Canna Cabana operates a retail cannabis chain with approximately 219 branded stores operating across Canada.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million, a 25% year-over-year increase, marking the fastest growth rate in the past 10 quarters, indicating strong market performance and competitiveness.
- Improved Adjusted EBITDA: The adjusted EBITDA reached $11.5 million, up 62% year-over-year, reflecting significant enhancements in cost control and operational efficiency, bolstering confidence in future profitability.
- Strong Membership Growth: Canna Cabana membership grew to 2.58 million, a 47% increase year-over-year, while ELITE membership doubled to 162,000, showcasing the company's success in customer loyalty and market penetration.
- Positive Free Cash Flow: The company generated $2.9 million in free cash flow in Q1, a substantial improvement from negative $1.9 million in the same quarter last year, indicating a healthy shift in cash flow status and providing funding support for future investments and expansion.
See More
- Significant Revenue Growth: High Tide reported Q1 revenue of $178.3 million for the three months ended January 31, 2026, reflecting a 25.2% year-over-year increase and exceeding market expectations by $51.47 million, demonstrating the company's ability to sustain growth in a competitive market.
- Record Gross Profit: The gross profit for the quarter reached $44.4 million, up 25% year-over-year and 4% sequentially, with a gross margin of 25%, indicating ongoing improvements in cost control and sales efficiency.
- Substantial Free Cash Flow Improvement: The company generated $2.9 million in free cash flow in Q1, a significant turnaround from $(1.9) million year-over-year and $1.3 million sequentially, enhancing its financial stability and operational flexibility.
- Net Loss Reduction: Although the company reported a net loss of $0.4 million in Q1, this marked a significant improvement from a net loss of $2.7 million year-over-year and $46.7 million sequentially, primarily due to reduced non-cash impairment expenses, indicating progress in profitability.
See More
- Earnings Announcement: High Tide (HITI) is set to release its Q1 2023 earnings report on March 17 after market close, with consensus EPS estimate at $0.00 and revenue estimate at $126.83 million, reflecting an 11% year-over-year decline.
- Historical Performance: Over the past two years, HITI has beaten EPS estimates 25% of the time while achieving a 100% success rate in beating revenue estimates, indicating strong revenue reliability.
- Market Volatility Impact: Despite reporting strong Q4 2025 results, the ongoing volatility in the cannabis sector poses challenges for High Tide's future financial performance, potentially affecting investor confidence.
- Investment Strategy Insight: High Tide's strategy of selling cash-secured puts for income investing is viewed as effective, yet market caution regarding its future performance necessitates close attention to the upcoming earnings report to assess the company's outlook.
See More
- New Store Opening: High Tide's Canna Cabana retail store in Sarnia, Ontario, is set to open on March 9, 2026, marking the company's entry into this market and increasing its total store count to 220 across Canada.
- Market Positioning: Located on London Road near Lambton Mall, the new store offers excellent visibility and is expected to attract local consumers seeking value and a diverse shopping experience, thereby enhancing the company's competitive edge.
- Financial Results Release: High Tide will release its financial and operational results for the quarter ending January 31, 2026, on March 17, 2026, followed by a webcast on March 18 to discuss the results and future outlook, further boosting investor confidence.
- Ongoing Expansion Strategy: Founder Raj Grover emphasized that despite having 220 stores, there are still significant organic growth opportunities, and the company will continue to focus on data-driven site selection strategies to support long-term growth.
See More
- New Store Opening: High Tide's Canna Cabana retail store in Sarnia, Ontario, is set to open on March 9, 2026, marking the company's first entry into this market and further expanding its footprint in Southwestern Ontario.
- Store Count Growth: This opening brings High Tide's total Canna Cabana locations to 220 across Canada, with 96 in Ontario, demonstrating the company's ongoing expansion and market penetration capabilities nationwide.
- Market Positioning Advantage: The new store is strategically located on London Road near Lambton Mall, surrounded by nationally recognized retailers, which will enhance visibility and foot traffic, potentially boosting sales performance.
- Financial Results Announcement: High Tide will release its financial and operational results for the quarter ending January 31, 2026, on March 17, 2026, followed by a webcast on March 18 to discuss future financial outlooks, further strengthening investor confidence.
See More
- Policy Transition Opportunity: High Tide Inc. announced its membership in the National Compassionate Care Council (NCCC) to help shape U.S. federal and state medical cannabis policies, indicating the company's proactive role in policy transformation aimed at improving patient access to cannabinoid therapies.
- Industry Leadership Position: The inclusion of NuLeaf Naturals, a leading U.S. CBD subsidiary, highlights High Tide's influence in the cannabis sector, particularly in advancing evidence-based policies and healthcare standards.
- Market Potential: With recent federal initiatives to reschedule cannabis and explore Medicare reimbursement, High Tide's U.S. CBD subsidiaries are poised to benefit, potentially expanding market share and enhancing business growth prospects.
- Brand Value Enhancement: By collaborating with the NCCC, High Tide can leverage its expertise in health brand development to strengthen brand image and increase consumer trust in its products, thereby driving sales growth.
See More









